Who owns FRLN - FREELINE THERAPEUTICS HLDGS - SPONSORED ADS based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

FREELINE THERAPEUTICS HLDGS - SPONSORED ADS (FRLN) Institutional Ownership

Q: What is CUSIP 35655L206?

CUSIP 35655L206 is the security identifier used in SEC filing datasets for FRLN - FREELINE THERAPEUTICS HLDGS - SPONSORED ADS.

CUSIP: 35655L206

13F Institutional Holders and Ownership History from Q2 2023 to Q1 2024

Type / Class: Equity / SPONSORED ADS
Symbol: FRLN

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Investment Quick Answers

What is CUSIP 35655L206?
CUSIP 35655L206 identifies FRLN - FREELINE THERAPEUTICS HLDGS - SPONSORED ADS in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Continue Investment Research

Latest 13F filings for new institutional portfolio disclosures.
Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
Latest 10-Q/10-K reports to cross-check issuer fundamentals.
Recent insider transactions for management buying/selling context.
SEC investors directory and top value investors for manager-level discovery.
All institutional ownership pages to compare adjacent CUSIP pages.

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP 35655L206:

Q1 2024 (0 holders) Q4 2023 (13 holders) Q3 2023 (11 holders) Q2 2023 (10 holders)

Institutional Holders of FREELINE THERAPEUTICS HLDGS - SPONSORED ADS (FRLN) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Price (Median)	Investors
2024 Q1	0	$0	-$2,538,669		0
2023 Q4	398,596	$2,538,669	-$1,114,963	$6.37	13
2023 Q3	855,223	$3,654,121	+$1,652,262	$4.30	11
2023 Q2	506,632	$1,306,074	+$1,306,074	$2.58	10